Hemarus Therapeutics Limited

Produces life-saving biopharmaceutical products for bleeding disorders with US FDA approved facility.

2003 | Hyderabad, Telangana (India) | Active
Last Updated:

Hemarus Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 1.00 M
  • Company Age 21 Year, 5 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 75.40 Cr
  • Revenue Growth -84.64%
  • Profit Growth -275.80%
  • Ebitda -716.81%
  • Net Worth -73.64%
  • Total Assets -87.88%

About Hemarus Therapeutics

Hemarus Therapeutics Limited (HTL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 September 2003 and has a history of 21 years and five months. Its registered office is in Hyderabad, Telangana, India.

The Corporate was formerly known as Hemarus Therapeutics Private Limited. The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 1.00 M.

The company has closed loans amounting to ₹75.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Talari Venkatesh, Satish Ganne, and Satish Saudam serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    hemarus.co.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74220TG2003PLC041698

  • Company No.

    041698

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    16 Sep 2003

  • Date of AGM

    29 Aug 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Life Sciences

What products or services does Hemarus Therapeutics Limited offer?

Hemarus Therapeutics Limited offers a wide range of products and services, including Immunomodulator Drugs, Normal Immunoglobulin Injection, Medical Consultancy Services, Health Care Consultancy Service.

Who are the key members and board of directors at Hemarus Therapeutics?

Board Members (3)

NameDesignationAppointment DateStatus
Talari Venkatesh Country flag representing In Director 06-Aug-2022Current
Satish Ganne Country flag representing In Director 03-Sep-2021Current
Satish Saudam Country flag representing In Director 30-Sep-2021Current

Financial Performance of Hemarus Therapeutics.

Hemarus Therapeutics Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.64% decrease. The company also saw a substantial fall in profitability, with a 275.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.64%.

Hemarus Therapeutics revenue growth over time
Hemarus Therapeutics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-84.64%
Revenue from Operations
-72.19%
Total Assets
-87.88%
Profit or Loss
-275.80%
Net Worth
-73.64%
EBITDA
-716.81%

What is the Ownership and Shareholding Structure of Hemarus Therapeutics?

In 2022, Hemarus Therapeutics had a promoter holding of 90.54% and a public holding of 9.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹75.40 Cr

Charges Breakdown by Lending Institutions

  • Indian Overseas Bank : 66.68 Cr
  • Andhra Pradesh State Financial Corporation : 8.72 Cr

Latest Charge Details

DateLenderAmountStatus
26 Feb 2011Indian Overseas Bank₹66.68 CrSatisfied
10 Aug 2004Andhra Pradesh State Financial Corporation₹8.72 CrSatisfied

How Many Employees Work at Hemarus Therapeutics?

Hemarus Therapeutics has a workforce of 68 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Hemarus Therapeutics Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemarus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemarus Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Hemarus Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Hemarus Therapeutics Limited last Annual general meeting of members was held on 29 Aug 2022 as per latest MCA records.

  • Director Appointment

    Talari Venkatesh was appointed as a Director was appointed as a Director on 06 Aug 2022 & has been associated with this company since 2 years 6 months .

  • Balance Sheet

    Hemarus Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.

  • Director Appointment

    Satish Narayan Saudam was appointed as a Director was appointed as a Director on 30 Sep 2021 & has been associated with this company since 3 years 5 months .

  • Director Appointment

    Satish Ganne was appointed as a Director was appointed as a Director on 03 Sep 2021 & has been associated with this company since 3 years 6 months .

  • Charges

    A charge registered on 26 Feb 2011 via Charge ID 10280683 with Indian Overseas Bank was fully satisfied on 27 Jan 2021.

Frequently asked questions

  • What is the Incorporation or founding date of Hemarus Therapeutics Limited?

    Hemarus Therapeutics Limited was incorporated on 16 Sep 2003.

  • What is authorized share capital and paid-up capital of Hemarus Therapeutics Limited?

    The authorized share capital of Hemarus Therapeutics Limited is ₹ 40.00 Cr and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Hemarus Therapeutics Limited?

    Currently 3 directors are associated with Hemarus Therapeutics Limited.

    • Talari Venkatesh
    • Satish Ganne
    • Satish Narayan Saudam

  • What is the registered address of Hemarus Therapeutics Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Hemarus Therapeutics Limited is 8-2-293/82/Jiii/359 Plot No.359-Iii Raod No.80, Jubilee Hills India, Shaikpet, Telangana, 500033.

  • What is the corporate identification number (CIN) and company number of Hemarus Therapeutics Limited?

    The corporate identification number (CIN) of Hemarus Therapeutics Limited is U74220TG2003PLC041698 and the company number is 041698 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Hemarus Therapeutics Limited?

    The Official website of Hemarus Therapeutics Limited is https://www.hemarus.co.in

  • What has been the recent revenue trend for Hemarus Therapeutics Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Hemarus Therapeutics Limited has fallen by -84.64%.

  • How many employees does Hemarus Therapeutics Limited currently have?

    As Per 2022 financial reports, 68 employees are currently employed by Hemarus Therapeutics Limited.

  • What change has been observed in the net worth of Hemarus Therapeutics Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Hemarus Therapeutics Limited has experienced an downturn of -73.64%.

  • When was the last Balance Sheet of Hemarus Therapeutics Limited filed with the ROC?

    The most recent Balance Sheet for Hemarus Therapeutics Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Biotechnology